Daiichi-Sankyo (South Korea)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (South Korea), South Korea, covering academic research published from 2002 to 2023. Read More.
Open Access Percentage
77%
Total
Publications
248
Total Open
Publications
192
Total
Citations
6.5K
Open Access
Percentage
77%
Total
Publications
248
Total Open
Publications
192
Total
Citations
6.5K
Breakdown
Publisher Open
49%
Both
19%
Other Platform Open
9%
Closed
23%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 11%
18
Hybrid 22%
38
No Guarantees 67%
114
Other Platform Open
Domain 73%
51
Institution 30%
21
Preprint 14%
10
Other Internet 7%
5
Public 4%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 50 |
Europe PMC | Domain | 26 |
DOI | Other Internet | 12 |
Research Square | Preprint | 9 |
University of Birmingham - University of Birmingham Research Portal | Institution | 5 |
Semantic Scholar | Public | 3 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 2 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 2 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 2 |
University of California - eScholarship University of California | Institution | 2 |